Navigation Links
Frost & Sullivan Lauds LI-COR Biosciences for Developing NIR Fluorescence, One of the Most Remarkable Advancements in the Biomedical Industry
Date:9/18/2013

MOUNTAIN VIEW, Calif., Sept. 18, 2013 /PRNewswire/ -- Based on its recent analysis of the in-vivo molecular imaging market, Frost & Sullivan recognizes LI-COR Biosciences with the 2013 North American Frost & Sullivan Award for Technology Leadership for its near-infrared (NIR) fluorescence technologies. LI-COR has joined hands with various institutions and organizations to achieve a smooth interaction among instruments, kits, and reagents providers.

"As NIR can penetrate depths of several centimeters, it improves the sensitivity of images. It also enables labs to eliminate image processing for spectral unmixing, as the NIR wavelength range has low tissue autofluorescence," said Frost & Sullivan Senior Research Analyst Cecilia Van Cauwenberghe. "These natural advantages of NIR make it ideal for early detection of diseases and, eventually, enhancement of therapeutic protocols."

The appropriate targeting agents for NIR optical imaging can be selected based on well-characterization and specificity in the evaluated compounds. LI-COR Biosciences offers a range of ready-to-use IRDye optical probes capable of targeting a variety of diseases. The IRDye 800CW infrared dye, a fluorescent label developed for numerous targeting agents, including peptides, small molecules, antibodies, antibody drugs, Affibody® molecules, and viruses, has been widely adopted and cited in scientific literature. These agents are compatible with most NIR fluorescence imagers.

BrightSite™ agents, another leading optical imaging tool from LI-COR, allow researchers to begin their experiments without developing new imaging probes. BrightSite™ agents are rigorously validated to ensure high purity, affinity, and specificity.

LI-COR also developed its proprietary Pearl® Impulse Imager, which has been optimized for dual-channel NIR optical imaging. This technology, based on laser excita
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Frost & Sullivan Lauds Adcock Ingrams Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets
2. Frost & Sullivan: Shortcomings in Medical Imaging Workflow Severely Impact Radiologists Productivity
3. Berg Receives Frost & Sullivan 2013 Drug Discovery Technology Innovation Award
4. End Users Desire for Greater Control over Production Processes Increases Adoption of SISs in Europe, Finds Frost & Sullivan
5. Frost & Sullivan: Demand for Faster Healing Spurs Sale of Advanced Wound Care and Modern Wound Closure Devices in Asia-Pacific
6. Frost & Sullivan: What are the forces pushing healthcare informatics to the next level?
7. Siemens Healthcare Takes Top Honors in Both Market Shares and Technology, Making it Frost & Sullivans Company of the Year in Interventional Radiology
8. iSonea Receives Frost & Sullivan New Product Innovation Leadership Award for its Path-Breaking Mobile Asthma Monitoring App, AsthmaSense
9. Increasing Demand from End-user Applications Boosts Asia-Pacific Antimicrobial Coatings Market, Finds Frost & Sullivan
10. Frost & Sullivan Recognizes ASCEND HiT for Providing Extensive Value Enhancement to Industry Partners and Providers through its Best-of-Breed Products
11. Frost & Sullivan Recognizes Nonin Medical with 2013 North American Pulse Oximetry Devices Product Quality Leadership Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Restore Health, a leading ... pharmaceuticals, announced that it is now offering pharmacogenetics ... each individual based upon their particular genetic makeup. ... the interaction between a patient,s genetics and their ... excited to provide this new service to healthcare ...
(Date:7/24/2014)... CITY, Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis systems, today reported financial results for ... First quarter overview: , Revenues of $47.5 ... , Diluted EPS of $0.21, up 50% over last ... Medical market revenues of $7.2 million, up 20% over ...
(Date:7/24/2014)... MOUNTAIN VIEW, Calif. , July 24, 2014 ... ), a leading provider of medication and supply ... hold a conference call Thursday, July 31, to ... What:  , Omnicell Second Quarter 2014 earnings ... 2014, 1:30 p.m. PTWho:  , Randall Lipps, chairman, ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... HILL, N.C., June 13, 2011 An organization,s ... stakeholders informed about a company,s vision, commitment, progress ... approach to integrate wide range of scattered activities ... in a continuously changing business environment. ...
... Therapeutics, Inc. (OTCBB: NVLT), a pharmaceutical company developing novel ... Harry S. Palmin, President and CEO of Novelos, will present ... Conference on Thursday, June 16, 2011, at 11:30 a.m. Eastern ... be accessed at www.novelos.com The webcast ...
Cached Medicine Technology:Effective Communications Programs Build Corporate Reputation and Reduce Risk 2Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16 2Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16 3
(Date:7/24/2014)... July 24, 2014 Memantine was initially developed ... marketed in Germany under the brand name Akatinol; it was ... as Ebixa and in the USA to Forest Labs as ... million in 2013. In the US, Forest reported Namenda sales ... expiry in Canada, Australia and the European region has increased ...
(Date:7/24/2014)... July 24, 2014 As the age ... to egg freezing as a way to ensure future ... otherwise decline with advancing reproductive age. Vitrification technology, a ... cutting edge medical technology that allows a woman to ... peak fertility years, which are then stored for future ...
(Date:7/24/2014)... with high-throughput data generated by breast cancer biologists ... computational method to determine how gene networks are ... as they respond to potential cancer therapy agents., ... each other in laboratory-grown cells is described in ... PLOS Computational Biology . , The method ...
(Date:7/24/2014)... In a recent report by CBS News, the district ... to criminal penalties associated with possession of small amounts of ... in Washington DC, giving it one of the most tolerant ... for possession of one ounce of marijuana or less with ... than an ounce of marijuana remain criminal offenses under the ...
(Date:7/24/2014)... from Penn Medicine shows that incisionless transcatheter aortic ... stay by 30 percent and has no impact ... conventional transfemoral TAVR, which requires an incision in ... the current issue of Circulation: Cardiovascular Interventions ... aortic valve without a traditional open-heart surgical approach. ...
Breaking Medicine News(10 mins):Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Penn study: Incisionless transcatheter aortic valve replacement surgery cuts hospital length of stay 2
... program for patients at high risk of developing skin ... melanomas at early stages and with good prognosis, according ... in the May print issue of Archives of ... to improve melanoma prognosis have focused on identifying and ...
... HealthDay Reporter , MONDAY, Jan. 17 (HealthDay News) -- ... the development of psychological disorders such as depression, researchers say. ... more likely to become addicted to video games (which the ... lot of hours playing these games, have trouble fitting in ...
... MONDAY, Jan. 17 (HealthDay News) -- New research shows that ... much higher for people taking warfarin, the most commonly used ... more than 1.23 million patients who went to emergency rooms ... as likely to die (9.3 percent vs. 4.8 percent). ...
... Jan. 17 (HealthDay News) -- Being poor can prevent young children ... study shows. Researchers at the University of Texas at Austin ... cognitive ability at ages 10 months and 2 years. During the ... a string to ring a bell, placing three cubes in a ...
... Jan. 15 (HealthDay News) -- Cigarettes start to destroy ... indicates, suggesting that the habit causes immediate genetic damage ... "The results reported here should serve as a stark ... cigarettes," lead study author Stephen S. Hecht, from the ...
... scientists are a step closer to developing a vaccine ... bone and joint surgery. Other MRSA vaccine research ... because of the inability to identify an agent that ... other research has targeted the surface of the bacteria, ...
Cached Medicine News:Health News:Follow-up program helps detect melanoma earlier in high-risk patients 2Health News:Video Game 'Addiction' Tied to Depression, Anxiety in Kids 2Health News:Video Game 'Addiction' Tied to Depression, Anxiety in Kids 3Health News:Warfarin Use May Raise Risk of Death From Traumatic Injuries 2Health News:Warfarin Use May Raise Risk of Death From Traumatic Injuries 3Health News:Smoking Damages DNA Within Minutes, Research Shows 2Health News:Researchers unzip MRSA and discover route for vaccine 2Health News:Researchers unzip MRSA and discover route for vaccine 3
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
... is an Auto Refractor/Keratometer with ... refinement. Electronic elevation, automatic alignment, ... accuracy and all the other ... Marco Automatic Refractors/Keratometer famous, make ...
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Medicine Products: